truxal 50 mg apvalkotās tabletes
h. lundbeck a/s, denmark - hlorprotiksēns - apvalkotā tablete - 50 mg
truxal 25 mg apvalkotās tabletes
h. lundbeck a/s, denmark - hlorprotiksēns - apvalkotā tablete - 25 mg
linezolid polpharma 600 mg apvalkotās tabletes
pharmaceutical works polpharma sa, poland - linezolīds - apvalkotās tabletes - 600 mg
apel 600 mg apvalkotās tabletes
medochemie ltd., cyprus - linezolīds - apvalkotā tablete - 600 mg
zydelig
gilead sciences ireland uc - idelalisib - lymphoma, non-hodgkin; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, other antineoplastic agents - zydelig is indicated in combination with an anti‑cd20 monoclonal antibody (rituximab or ofatumumab) for the treatment of adult patients with chronic lymphocytic leukaemia (cll):who have received at least one prior therapy, oras first line treatment in the presence of 17p deletion or tp53 mutation in patients who are not eligible for any other therapies. zydelig is indicated as monotherapy for the treatment of adult patients with follicular lymphoma (fl) that is refractory to two prior lines of treatment.
haloperidol-richter 50 mg/ml šķīdums injekcijām
gedeon richter plc., hungary - haloperidols - Šķīdums injekcijām - 50 mg/ml
haloperidol-richter 2 mg/ml pilieni iekšķīgai lietošanai, šķīdums
gedeon richter plc., hungary - haloperidols - pilieni iekšķīgai lietošanai, šķīdums - 2 mg/ml
haloperidol-richter 5 mg/ml šķīdums injekcijām
gedeon richter plc., hungary - haloperidols - Šķīdums injekcijām - 5 mg/ml
haloperidol-richter 1,5 mg tabletes
gedeon richter plc., hungary - haloperidols - tablete - 1,5 mg
darunavir sandoz 75 mg apvalkotās tabletes
sandoz d.d., slovenia - darunavīrs - apvalkotā tablete - 75 mg